D. T. Edizer Et Al. , "Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer," European Review for Medical and Pharmacological Sciences , vol.28, no.6, pp.2168-2178, 2024
Edizer, D. T. Et Al. 2024. Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer. European Review for Medical and Pharmacological Sciences , vol.28, no.6 , 2168-2178.
Edizer, D. T., Leblebici, A., Ergun, U., Yilmaz, F., Koc, A., BAŞBINAR, Y., ... Ellidokuz, E.(2024). Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer. European Review for Medical and Pharmacological Sciences , vol.28, no.6, 2168-2178.
Edizer, DENİZ Et Al. "Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer," European Review for Medical and Pharmacological Sciences , vol.28, no.6, 2168-2178, 2024
Edizer, DENİZ T. Et Al. "Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer." European Review for Medical and Pharmacological Sciences , vol.28, no.6, pp.2168-2178, 2024
Edizer, D. T. Et Al. (2024) . "Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer." European Review for Medical and Pharmacological Sciences , vol.28, no.6, pp.2168-2178.
@article{article, author={DENİZ TUNA EDİZER Et Al. }, title={Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer}, journal={European Review for Medical and Pharmacological Sciences}, year=2024, pages={2168-2178} }